Copper(II)-containing nickel(II) hydroxide particles, i.e., α-Ni 1 - x Cu x (OH) 2 (0 < x ≤ 0.4), have been prepared by aging 0.5 mol dm - 3 urea, Ni(NO 3 ) 2, and Cu(NO 3 ) 2 solutions at 363 K. After 3 h, coprecipitation is almost complete. The formed solids, characterized by powder X-ray diffraction, scanning electron microscopy, energy dispersion X-ray spectroscopy, and Fourier transform infrared spectroscopy, preserve the typical characteristics of α-Ni(OH) 2 . Still, their chemical composition, i.e., the copper-to-nickel ratio, is nearly that of the initial solutions. The analysis of the processes that take place during the formation of α-Ni 1 - x Cu x (OH) 2 indicates that, although Cu(II) and Ni(II) precipitation are separate events, the simultaneity of am -Cu(OH) 2 (amorphous copper(II) hydroxide) redissolution and α-Ni(OH) 2 growth provides the appropriate conditions for the intercalation of aqueous Cu(II) species within the interlayer space of the growing α-Ni(OH) 2 particles. Upon mild thermal treatment, i.e., T ≥ 523 K, α-Ni 1 - x Cu x (OH) 2 powders are readily converted in Ni 1 - x Cu x O (bunsenite), provided x ≤ 0.33; when x is larger than 0.33, the thermodynamically expected segregation of tenorite is realized. The ease of Ni 1 - x Cu x O (bunsenite) formation is rationalized in terms of the topotatic relationship between the layered structure of the precursors and the rock salt structure of the mixed oxide.
No takes yet. Share an insight, caveat, or question.
Jobbágy et al. (1998) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: